Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: An improved understanding of lung cancer therapeutic intervention

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 5, 2012, Pages 1006-1014

  Garg, Neeraj K ^a,b   Dwivedi, Priya ^c   Campbell, Christopher ^d   Tyagi, Rajeev K ^d  

^a PANJAB UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

^c TRS Colloege ^*  (India)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anisamide; Chitosan; Gemcitabine; Lung cancer targeting; Nanoparticles; Poly(ethylene glycol)

Indexed keywords

CHITOSAN; GEMCITABINE; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG TARGETING; DRUG TUMOR LEVEL; DRUG UPTAKE; ENCAPSULATION; EX VIVO STUDY; FREEZE DRYING; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; LUNG CANCER; MOUSE; NEPHROTOXICITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR VOLUME; ZETA POTENTIAL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ASPARTATE AMINOTRANSFERASES; BENZAMIDES; CELL LINE, TUMOR; CHITOSAN; DEOXYCYTIDINE; DRUG CARRIERS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASMS; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; UREA;

EID: 84868685988     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.09.012     Document Type: Article

References (36)

1. J.L. Abbruzzese, R. Grunewald, E.A. Weeks, D. Gravel, T. Adams, and B. Nowak A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J. Clin. Oncol. 9 1991 491 498
2. A. Agarwal, U. Gupta, A. Asthana, and N.K. Jain Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent Biomaterials 30 2009 3588 3596
3. S.A. Agnihotri, N.N. Mallikarjuna, and T.M. Aminabhavi Recent advances on chitosan-based micro-and nanoparticles in drug delivery J. Control Release 100 2004 5 28 (Pubitemid 39445982)
4. T.A. Ajith, M.S. Aswathy, and U. Hema Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity Food Chem. Toxicol. 46 2008 3178 3181
5. G. Arya, M. Vandana, S. Acharya, and S.K. Sahoo Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy Nanomed.: Nanotechnol., Biol., Med. 6 2011 859 870
6. R. Banerjee, P. Tyagi, S. Li, and L. Huang Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells Int. J. Can. 112 2004 693 700 (Pubitemid 39425952)
7. T. Banerjee, S. Mitra, A.K. Singh, R.K. Sharma, and A. Maitra Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles Int. J. Pharm. 243 2002 93 105
8. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 2007 748 758 (Pubitemid 47320813)
9. H.A. Burris 3rd, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, and M.R. Modiano Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 1997 2403 2413 (Pubitemid 27251144)
10. P. Calvo, C. Remuñán-López, J.L. Vila-Jato, and M.J. Alonso Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers J. Appl. Polym. Sci. 63 1997 125 132 (Pubitemid 127613982)
11. Y.W. Cho, S.A. Park, T.H. Han, D.H. Son, J.S. Park, and S.J. Oh In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications Biomaterials 28 2007 1236 1247 (Pubitemid 44816372)
12. M. Das, C. Mohanty, and S.K. Sahoo Ligand-based targeted therapy for cancer tissue Expert Opin. Drug Deliv. 6 2009 285 304
13. A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, and D. Papahadjopoulos Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies Can. Res. 50 1990 6371 6378 (Pubitemid 20323703)
14. X.H. Gao, Y.Y. Cui, R.M. Levenson, L.W.K. Chung, and S.M. Nie In vivo cancer targeting and imaging with semiconductor quantum dots Nat. Biotechnol. 22 2004 969 976 (Pubitemid 39014473)
15. O.B. Garbuzenko, M. Saad, V.P. Pozharov, K.R. Reuhl, G. Mainelis, and T. Minko Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance Proc. Natl. Acad. Sci. USA 107 2010 10737 10742
16. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603 (Pubitemid 24128361)
17. P. Huang, and W. Plunkett Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event Can. Chemother. Pharmacol. 36 1995 181 188
18. M.L. Immordino, P. Brusa, F. Rocco, S. Arpicco, M. Ceruti, and L. Cattel Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs J. Control Release 100 2004 331 346 (Pubitemid 39572916)
19. R. Injac, M. Perse, N. Obermajer, V. Djordjevic-Milic, M. Prijatelj, A. Djordjevic, A. Cerar, and B. Strukelj Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas Biomaterials 29 2008 3451 3460
20. J.A. Ko, H.J. Park, S.J. Hwang, J.B. Park, and J.S. Lee Preparation and characterization of chitosan microparticles intended for controlled drug delivery Int. J. Pharm. 249 2002 165 174 (Pubitemid 35333443)
21. P. Kolhe, E. Misra, R.M. Kannan, S. Kannan, and M. Lieh-Lai Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers Int. J. Pharm. 259 2003 143 160 (Pubitemid 36638561)
22. S.D. Li, and L. Huang Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells Mol. Pharm. 3 5 2006 579 588 (Pubitemid 44639135)
23. J.R. Mackey, S.Y. Yao, K.M. Smith, E. Karpinsk, S.A. Baldwin, C.E. Cass, and J.D. Young Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters J. Natl. Can. Inst. 91 1991 1876 1881
24. K. Na, T.B. Lee, K.H. Park, E.K. Shin, Y.B. Lee, and H.K. Choi Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system Eur. J. Pharm. Sci. 18 2003 165 173 (Pubitemid 36184755)
25. D. Paolino, D. Cosco, L. Racanicchi, E. Trapasso, C. Celia, and M. Iannone Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity J. Control Release 144 2010 144 150
26. G. Pasut, F. Canal, L. Dalla Via, S. Arpicco, F.M. Veronese, and O. Schiavon Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid J. Control Release 127 2008 239 248
27. L.H. Reddy, and P. Couvreur Novel approaches to deliver gemcitabine to cancers Curr. Pharm. Design. 14 2008 1124 1137 (Pubitemid 351982559)
28. K. Robinson, L. Lambiase, J. Li, C. Monteiro, and M. Schiff Fatal cholestatic liver failure associated with gemcitabine therapy Dig. Dis. Sci. 48 2003 1804 1808 (Pubitemid 37174737)
29. S.K. Sahoo, and V. Labhasetwar Nanotech approaches to drug delivery and imaging Drug Discov. Today 8 2003 1112 1120 (Pubitemid 37547917)
30. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
31. Q. Tian, C.N. Zhang, X.H. Wang, W. Wang, W. Huang, and R.T. Cha Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery Biomaterials 31 2010 4748 4756
32. W. Tiyaboonchai Chitosan nanoparticles: a promising system for drug delivery Naresuan Univ. J. 11 2003 51 66
33. B.J. Vilner, C.S. John, and W.D. Bowen Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines Can. Res. 55 1995 408 413
34. J.M. Walker, W.D. Bowen, F.O. Walker, R.R. Matsumoto, B. De Costa, and K.C. Rice Sigma receptors: biology and function Pharm. Rev. 42 1990 355 402
35. B. Wilson, M.K. Samanta, K. Santhi, K.P. Kumar, M. Ramasamy, and B. Suresh Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine Nanomedicine 6 2010 144 152
36. H.S. Yoo, and T.G. Park Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate J. Control Release 100 2004 247 256 (Pubitemid 39491276)